• R&D
    Overview
Clinical Trials San Francisco ARENSIA Spotlight1981427193

ARENSIA Spotlight

The New Normal in Exploratory Clinical Trials: Challenges and Future Trends

Our Unique Meeting Format

Meet the Facilitators

The Spotlight will be lead by our expert facilitators:

Claudia Hesselmann, PhD

Co-founder & CEO ARENSIA

Heather Paden

VP, Clinical Operations PureTech Health, Boston, USA

Cara Pilowa

Senior Director, Clinical Operations VirBio Inc., San Francisco, USA

Alina Jucov, Assoc. Prof, MD, PhD

Principal Investigator & Medical Director ARENSIA Research Clinic, Chisinau, Moldova

Julia Ford

Associate Director, Clinical Operations Gossamer Bio, San Diego, USA

Evgeny Levenko, MD, PhD

Country Manager ARENSIA Research Clinic, Kyiv, Ukraine

Melanie Flores

Client Services, Early Phase Center of Excellence Advarra

Megha Patel

Associate Director, Global Trial Leader Johnson & Johnson

Olga Carvalho

Principal Clinical Trial Leader Genentech

More about ARENSIA

ARENSIA EXPLORATORY MEDICINE is a German operator of proprietary research clinics in Eastern Europe, dedicated to performing complex Phase Ib, IIa and PROOF-OF-CONCEPT clinical trials with novel molecules, involving patients across numerous disease areas. Given the outstanding patient recruitment rates achieved by ARENSIA clinics, we are able to substantially reduce the overall number of sites, countries and recruitment periods for any early phase patient trial.

Further Information

480 Sutter Street,San Francisco, CA, 94108